title: Trastuzumab-related cardiotoxicity in the herceptin adjuvant trial.
authors.forename: Filippo
authors.initials: F
authors.lastname: Montemurro
authors.forename: Stefania
authors.initials: S
authors.lastname: Redana
authors.forename: Giorgio
authors.initials: G
authors.lastname: Valabrega
authors.forename: Rossella
authors.initials: R
authors.lastname: Martinello
authors.forename: Massimo
authors.initials: M
authors.lastname: Aglietta
authors.forename: Renato
authors.initials: R
authors.lastname: Palmiero
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D017024:Chemotherapy, Adjuvant; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab